International Stem Cell Corp (ISCO)
0.0712
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
International Stem Cell Total Assets (Quarterly): 5.39M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.39M |
| September 30, 2023 | 5.641M |
| June 30, 2023 | 5.786M |
| March 31, 2023 | 5.341M |
| December 31, 2022 | 5.135M |
| September 30, 2022 | 5.042M |
| June 30, 2022 | 5.416M |
| March 31, 2022 | 5.501M |
| December 31, 2021 | 4.946M |
| September 30, 2021 | 4.937M |
| June 30, 2021 | 5.611M |
| March 31, 2021 | 6.019M |
| December 31, 2020 | 5.287M |
| September 30, 2020 | 5.851M |
| June 30, 2020 | 6.783M |
| March 31, 2020 | 6.876M |
| December 31, 2019 | 6.62M |
| September 30, 2019 | 8.26M |
| June 30, 2019 | 8.541M |
| March 31, 2019 | 8.663M |
| December 31, 2018 | 7.796M |
| September 30, 2018 | 8.725M |
| June 30, 2018 | 8.416M |
| March 31, 2018 | 7.468M |
| December 31, 2017 | 6.864M |
| Date | Value |
|---|---|
| September 30, 2017 | 7.953M |
| June 30, 2017 | 7.614M |
| March 31, 2017 | 7.855M |
| December 31, 2016 | 7.045M |
| September 30, 2016 | 7.54M |
| June 30, 2016 | 7.861M |
| March 31, 2016 | 8.388M |
| December 31, 2015 | 7.138M |
| September 30, 2015 | 7.23M |
| June 30, 2015 | 6.885M |
| March 31, 2015 | 6.693M |
| December 31, 2014 | 7.179M |
| September 30, 2014 | 6.364M |
| June 30, 2014 | 6.615M |
| March 31, 2014 | 6.652M |
| December 31, 2013 | 7.739M |
| September 30, 2013 | 6.927M |
| June 30, 2013 | 6.098M |
| March 31, 2013 | 6.815M |
| December 31, 2012 | 5.37M |
| September 30, 2012 | 7.116M |
| June 30, 2012 | 8.909M |
| March 31, 2012 | 10.59M |
| December 31, 2011 | 5.737M |
| September 30, 2011 | 7.325M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.937M
Minimum
Sep 2021
8.541M
Maximum
Jun 2019
5.946M
Average
5.611M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Electromed Inc | 46.96M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.577M |
| Shareholders Equity (Quarterly) | -4.187M |
| Debt to Equity Ratio | -0.8257 |
| Current Ratio | 0.7287 |
| Net Debt Paydown Yield | -6.69% |